Skip to content

Opening book details…

About this Immunology and Microbiology article

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma by Stephen Y. Chan; Alan N. Gordon; Robert E. Coleman; James B. Hall; Mark S. Berger; Matthew L. Sherman; Catharine B. Eten; Neil J. Finkler is a Immunology and Microbiology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Immunology and Microbiology.

Author
Stephen Y. Chan; Alan N. Gordon; Robert E. Coleman; James B. Hall; Mark S. Berger; Matthew L. Sherman; Catharine B. Eten; Neil J. Finkler
Publisher
Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0340-7004)
Published
2003
Language
EN
Field
Immunology and Microbiology (Life Sciences)

More by Stephen Y. Chan; Alan N. Gordon; Robert E. Coleman; James B. Hall; Mark S. Berger; Matthew L. Sherman; Catharine B. Eten; Neil J. Finkler

Browse all works by Stephen Y. Chan; Alan N. Gordon; Robert E. Coleman; James B. Hall; Mark S. Berger; Matthew L. Sherman; Catharine B. Eten; Neil J. Finkler